Multiple studies have shown that survivin inhibition, loss or downregulation triggers apoptosis of malignant cells, including GBM and medulloblastoma [172,173], and it has also been described as a prognostic indicator for GBM [174]. The gene discussed is BIRC5; the disease is glioblastoma.